1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69–90.
2. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005; 366:1784–1793.
3. Gazdar AF, Thun MJ. Lung cancer, smoke exposure, and sex. J Clin Oncol. 2007; 25:469–471.
4. Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009; 125:2936–2944.
5. Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol. 2007; 36:1048–1059.
6. Bae JM, Lee MS, Shin MH, Kim DH, Li ZM, Ahn YO. Cigarette smoking and risk of lung cancer in Korean men: the Seoul Male Cancer Cohort Study. J Korean Med Sci. 2007; 22:508–512.
7. Bae JM, Ahn YO. A nested case-control study on the high-normal blood pressure as a risk factor of hypertension in Korean middle-aged men. J Korean Med Sci. 2002; 17:328–336.
8. Shin MH, Kim DH, Bae JM, Lee HK, Lee MS, Noh JY, Ahn YO. The effect of coffee consumption on serum total cholesterol level in healthy middle-aged men. Korean J Prev Med. 1994; 27:200–216.
9. Kim DS, Koo HW, Kim DH, Bae JM, Shin MH, Lee MS, Lee CM, Ahn YO. A cohort study of physical activity and all cause mortality in middle-aged men in Seoul. Korean J Prev Med. 1998; 31:604–615.
10. Kim MK, Lee SS, Ahn YO. Reproducibility and validity of a self-administered semiquantitative food frequency questionnaire among middle-aged men in Seoul. Korean J Community Nutr. 1996; 1:376–394.
11. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. vol. VIII. Lyon: IARC Scientific Publications;2002. p. 276–277.
14. Szklo M, Nieto FJ. Epidemiology: beyond the basics. 2nd ed. Sudbury: Jones & Bartlett Publishers;2006. p. 183–212.
15. Wang X, Elston RC, Zhu X. The meaning of interaction. Hum Hered. 2010; 70:269–277.
16. StataCorp LP. Data analysis and statistical software. accessed on 15 January 2013. Available at
http://www.stata.com.
17. Case BW. Asbestos, smoking, and lung cancer: interaction and attribution. Occup Environ Med. 2006; 63:507–508.
18. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91:1194–1210.
19. Ahsan H, Thomas DC. Lung cancer etiology: independent and joint effects of genetics, tobacco, and arsenic. JAMA. 2004; 292:3026–3029.
20. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003; 123:21S–49S.
22. Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, Metayer C, Chen K, Lei S, Cui H, Lubin JH. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol. 2001; 30:118–123.
23. Alavanja MC, Brownson RC, Boice JD Jr, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992; 136:623–632.
24. Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008; 8:605–615.
25. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocytegenerated oxidants in carcinogenesis. Blood. 1990; 76:655–663.
26. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007; 117:1175–1183.
27. Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, Correa P. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995; 141:1023–1032.
28. Ardies CM. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther. 2003; 2:238–246.
29. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control. 2004; 15:819–827.
30. Song L, Yan W, Deng M, Song S, Zhang J, Zhao T. Aberrations in the fragile histidine triad (FHIT) gene may be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis. Tumour Biol. 2004; 25:270–275.